Press Releases

Press Releases

Sep 15, 2020
CRANFORD, N.J. , Sept. 15, 2020 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (the “Company” or “Enzon”) (OTC:ENZN) announced today the record date and expected subscription period for its previously-announced rights offering to raise proceeds of approximately $43 million .  The proceeds from the
Sep 2, 2020
CRANFORD, N.J. , Sept. 02, 2020 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (the “Company” or “Enzon”) (OTC:ENZN) today announced that its 2020 annual meeting of stockholders (the “Annual Meeting”) originally scheduled to be held on Thursday, September 17, 2020 , has been postponed and will now
Aug 21, 2020
CRANFORD, N.J. , Aug. 21, 2020 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (the “Company” or “Enzon”) (OTC: ENZN) today announced that its Board of Directors (the “Board”) has approved a rights offering to existing shareholders whereby the Company intends to distribute one transferable
Aug 14, 2020
CRANFORD, N.J. , Aug. 14, 2020 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (the “Company” or “Enzon”) (OTC:ENZN) today announced that its Board of Directors (the “Board”) adopted a tax benefits preservation plan (the “Section 382 Rights Plan”) designed to protect the availability of Enzon’s net
May 1, 2014
PISCATAWAY, N.J. --(BUSINESS WIRE)-- Enzon Pharmaceuticals, Inc.
Apr 23, 2013
PISCATAWAY, NJ -- (Marketwired) -- 04/23/13 -- Enzon Pharmaceuticals, Inc.
Mar 18, 2013
PISCATAWAY, NJ -- (Marketwire) -- 03/18/13 -- Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) today announced its financial results for the fourth quarter and full year 2012.
Dec 17, 2012
PISCATAWAY, NJ -- (Marketwire) -- 12/17/12 -- Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) today announced that its Board of Directors has retained Lazard to act as financial advisor in a review of the possible sale or disposition of one or more corporate assets, or a sale of the Company.
Nov 29, 2012
PISCATAWAY, NJ -- (Marketwire) -- 11/29/12 -- Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) today announced that its Board of Directors has authorized a special dividend of $2.00 per common share, payable on December 21, 2012 to shareholders of record as of December 10, 2012 .
Nov 8, 2012
PISCATAWAY, NJ -- (Marketwire) -- 11/08/12 -- Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) today announced two oral presentations at the 2nd Annual Symposium of Drug Delivery Systems-2012, which is being held November 8-10 in Nanjing , China .